U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H10N2O
Molecular Weight 150.1778
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BENZYL(METHYL)NITROSAMINE

SMILES

CN(CC1=CC=CC=C1)N=O

InChI

InChIKey=NGXUJKBJBFLCAR-UHFFFAOYSA-N
InChI=1S/C8H10N2O/c1-10(9-11)7-8-5-3-2-4-6-8/h2-6H,7H2,1H3

HIDE SMILES / InChI
Molecular Formula C8H10N2O
Molecular Weight 150.1778
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
149124
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:34:33 GMT 2025
Edited
by admin
on Mon Mar 31 18:34:33 GMT 2025
Record UNII
H81CGI9K6Z
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BENZYL(METHYL)NITROSAMINE
Common Name English
N-METHYL-N-BENZYLNITROSAMINE-
Preferred Name English
BENZENEMETHANAMINE, N-METHYL-N-NITROSO-
Systematic Name English
N-METHYL-N-NITROSOBENZENEMETHANAMINE
Systematic Name English
NMBA
Common Name English
N-METHYL-N-BENZYLNITROSAMINE
Common Name English
BENZYLAMINE, N-METHYL-N-NITROSO-
Systematic Name English
Code System Code Type Description
PUBCHEM
13643
Created by admin on Mon Mar 31 18:34:34 GMT 2025 , Edited by admin on Mon Mar 31 18:34:34 GMT 2025
PRIMARY
CHEBI
176579
Created by admin on Mon Mar 31 18:34:34 GMT 2025 , Edited by admin on Mon Mar 31 18:34:34 GMT 2025
PRIMARY
CAS
937-40-6
Created by admin on Mon Mar 31 18:34:34 GMT 2025 , Edited by admin on Mon Mar 31 18:34:34 GMT 2025
PRIMARY
SMS_ID
300000053182
Created by admin on Mon Mar 31 18:34:34 GMT 2025 , Edited by admin on Mon Mar 31 18:34:34 GMT 2025
PRIMARY
EPA CompTox
DTXSID3041081
Created by admin on Mon Mar 31 18:34:34 GMT 2025 , Edited by admin on Mon Mar 31 18:34:34 GMT 2025
PRIMARY
FDA UNII
H81CGI9K6Z
Created by admin on Mon Mar 31 18:34:34 GMT 2025 , Edited by admin on Mon Mar 31 18:34:34 GMT 2025
PRIMARY
Related Record Type Details
Structure of VALSARTAN
PARENT -> IMPURITY
Priority toxic pollutant.
Structure of Irbesartan
PARENT -> IMPURITY
Priority toxic pollutant.
Structure of CANDESARTAN
PARENT -> IMPURITY
Priority toxic pollutant.
Structure of AZILSARTAN
PARENT -> IMPURITY
Priority toxic pollutant.
Structure of EPROSARTAN
PARENT -> IMPURITY
Priority toxic pollutant.
Structure of Losartan
PARENT -> IMPURITY
NMBA is a priority toxic pollutant. FDA is temporarily not objecting to Losartan with NMBA below 9.82 ppm remaining on the market.
Structure of TELMISARTAN
PARENT -> IMPURITY
Priority toxic pollutant.
Structure of OLMESARTAN
PARENT -> IMPURITY
Priority toxic pollutant.
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966